vs

Side-by-side financial comparison of CARTERS INC (CRI) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.

Option Care Health, Inc. is the larger business by last-quarter revenue ($1.4B vs $757.8M, roughly 1.8× CARTERS INC). Option Care Health, Inc. runs the higher net margin — 3.4% vs 1.5%, a 1.8% gap on every dollar of revenue. On growth, Option Care Health, Inc. posted the faster year-over-year revenue change (1.3% vs -0.1%).

Carter's, Inc. is a major American designer and marketer of children's apparel. It was founded in 1865 by William Carter.

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

CRI vs OPCH — Head-to-Head

Bigger by revenue
OPCH
OPCH
1.8× larger
OPCH
$1.4B
$757.8M
CRI
Growing faster (revenue YoY)
OPCH
OPCH
+1.4% gap
OPCH
1.3%
-0.1%
CRI
Higher net margin
OPCH
OPCH
1.8% more per $
OPCH
3.4%
1.5%
CRI

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
CRI
CRI
OPCH
OPCH
Revenue
$757.8M
$1.4B
Net Profit
$11.6M
$45.3M
Gross Margin
45.1%
19.4%
Operating Margin
3.8%
5.4%
Net Margin
1.5%
3.4%
Revenue YoY
-0.1%
1.3%
Net Profit YoY
-80.1%
-3.0%
EPS (diluted)
$0.32
$0.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CRI
CRI
OPCH
OPCH
Q1 26
$1.4B
Q4 25
$1.5B
Q3 25
$757.8M
$1.4B
Q2 25
$585.3M
$1.4B
Q1 25
$629.8M
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.2B
Net Profit
CRI
CRI
OPCH
OPCH
Q1 26
$45.3M
Q4 25
$58.5M
Q3 25
$11.6M
$51.8M
Q2 25
$446.0K
$50.5M
Q1 25
$15.5M
$46.7M
Q4 24
$60.1M
Q3 24
$53.9M
Q2 24
$53.0M
Gross Margin
CRI
CRI
OPCH
OPCH
Q1 26
19.4%
Q4 25
19.3%
Q3 25
45.1%
19.0%
Q2 25
48.1%
19.0%
Q1 25
46.2%
19.7%
Q4 24
21.3%
Q3 24
20.1%
Q2 24
20.3%
Operating Margin
CRI
CRI
OPCH
OPCH
Q1 26
5.4%
Q4 25
6.2%
Q3 25
3.8%
5.9%
Q2 25
0.7%
5.8%
Q1 25
4.1%
5.9%
Q4 24
6.9%
Q3 24
6.7%
Q2 24
6.6%
Net Margin
CRI
CRI
OPCH
OPCH
Q1 26
3.4%
Q4 25
4.0%
Q3 25
1.5%
3.6%
Q2 25
0.1%
3.6%
Q1 25
2.5%
3.5%
Q4 24
4.8%
Q3 24
4.2%
Q2 24
4.3%
EPS (diluted)
CRI
CRI
OPCH
OPCH
Q1 26
$0.29
Q4 25
$0.37
Q3 25
$0.32
$0.32
Q2 25
$0.01
$0.31
Q1 25
$0.43
$0.28
Q4 24
$0.36
Q3 24
$0.31
Q2 24
$0.30

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CRI
CRI
OPCH
OPCH
Cash + ST InvestmentsLiquidity on hand
$184.2M
$177.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$864.6M
Total Assets
$2.5B
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CRI
CRI
OPCH
OPCH
Q1 26
$177.3M
Q4 25
$232.6M
Q3 25
$184.2M
$309.8M
Q2 25
$338.2M
$198.8M
Q1 25
$320.8M
$171.4M
Q4 24
$412.6M
Q3 24
$483.0M
Q2 24
$376.9M
Total Debt
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
Q3 25
$1.2B
Q2 25
$1.1B
Q1 25
$1.1B
Q4 24
$1.1B
Q3 24
$1.1B
Q2 24
$1.1B
Stockholders' Equity
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
$1.3B
Q3 25
$864.6M
$1.4B
Q2 25
$853.9M
$1.4B
Q1 25
$847.2M
$1.4B
Q4 24
$1.4B
Q3 24
$1.4B
Q2 24
$1.4B
Total Assets
CRI
CRI
OPCH
OPCH
Q1 26
$3.4B
Q4 25
$3.5B
Q3 25
$2.5B
$3.5B
Q2 25
$2.5B
$3.4B
Q1 25
$2.3B
$3.3B
Q4 24
$3.4B
Q3 24
$3.4B
Q2 24
$3.3B
Debt / Equity
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
Q3 25
0.86×
Q2 25
0.82×
Q1 25
0.82×
Q4 24
0.79×
Q3 24
0.78×
Q2 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CRI
CRI
OPCH
OPCH
Operating Cash FlowLast quarter
$-128.0M
Free Cash FlowOCF − Capex
$-144.1M
FCF MarginFCF / Revenue
-19.0%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
-11.04×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
$258.4M
Q3 25
$-128.0M
$139.4M
Q2 25
$40.3M
$90.3M
Q1 25
$-48.6M
$-7.2M
Q4 24
$36.1M
Q3 24
$160.4M
Q2 24
$195.7M
Free Cash Flow
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
Q3 25
$-144.1M
$130.2M
Q2 25
$24.1M
$81.2M
Q1 25
$-59.0M
$-16.6M
Q4 24
$25.8M
Q3 24
$150.7M
Q2 24
$185.9M
FCF Margin
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
Q3 25
-19.0%
9.1%
Q2 25
4.1%
5.7%
Q1 25
-9.4%
-1.2%
Q4 24
2.0%
Q3 24
11.8%
Q2 24
15.1%
Capex Intensity
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
Q3 25
2.1%
0.6%
Q2 25
2.8%
0.6%
Q1 25
1.6%
0.7%
Q4 24
0.8%
Q3 24
0.8%
Q2 24
0.8%
Cash Conversion
CRI
CRI
OPCH
OPCH
Q1 26
Q4 25
4.42×
Q3 25
-11.04×
2.69×
Q2 25
90.37×
1.79×
Q1 25
-3.13×
-0.15×
Q4 24
0.60×
Q3 24
2.98×
Q2 24
3.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CRI
CRI

Sales Channel Directly To Consumer$362.3M48%
Sales Channel Through Intermediary$283.8M37%
Other$110.4M15%
Gift Cards$1.3M0%

OPCH
OPCH

Segment breakdown not available.

Related Comparisons